Clinical trials
Completed Joint Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 10 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 90 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of British Columbia | 6 |
| Zimmer Biomet | 6 |
| Anderson Orthopaedic Research Institute | 2 |
| Brigham and Women's Hospital | 2 |
| Leiden University Medical Center | 2 |
| Mayo Clinic | 2 |
| Necmettin Erbakan University | 2 |
| Real Fundación Victoria Eugenia | 2 |
| Rush University Medical Center | 2 |
| Universidad Católica San Antonio de Murcia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Joint Diseases | 90 |
| Osteoarthritis | 31 |
| Arthritis | 25 |
| Musculoskeletal Diseases | 22 |
| Osteoarthritis, Knee | 17 |
| Rheumatic Diseases | 12 |
| Hemophilia A | 10 |
| Arthritis, Rheumatoid | 6 |
| Osteoarthritis, Hip | 4 |
| Obesity | 3 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.